Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Smyth

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 24, 2009
Oral prednisolone for preschool children with acute virus-induced wheezingJayachandran Panickar, Monica Lakhanpaul, Paul C Lambert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2007
Clinical trials in cystic fibrosisGerd Döring, J Stuart Elborn, Marie Johannesson, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patientsMichael Mulheran, Pauline Hyman-Taylor, Kelvin H-V Tan, et al.
Pediatrics|December 5, 2006
Asthma as a barrier to children's physical activity: implications for body mass index and mental healthCristine Glazebrook, Amy C McPherson, Ian A Macdonald, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2018
The prevalence, clinical status and genotype of cystic fibrosis patients living in Cuba using national registry dataFidel Rodríguez-Calá, Ramón Suárez-Medina, Silvia Josefina Venero-Fernández, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 11, 2024
Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registriesRebecca Calthorpe, Margaret Rosenfeld, Christopher H Goss, et al.
Lancet (London, England)|February 15, 2005
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trialAlan Smyth, Kelvin H-V Tan, Pauline Hyman-Taylor, et al.
BMJ Open Respiratory Research|September 9, 2020
How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative surveySherie Smith, Nicola Rowbotham, Gwyneth Davies, et al.
BMC Public Health|October 28, 2011
Evaluating the effectiveness of a schools-based programme to promote exercise self-efficacy in children and young people with risk factors for obesity: steps to active kids (STAK)Cris Glazebrook, Martin J Batty, Nivette Mullan, et al.
BMJ Open Respiratory Research|May 3, 2024
Considerations for the use of inhaled antibiotics for <i>Pseudomonas aeruginosa</i> in people with cystic fibrosis receiving CFTR modulator therapyPierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 24, 2009
Oral prednisolone for preschool children with acute virus-induced wheezingJayachandran Panickar, Monica Lakhanpaul, Paul C Lambert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2007
Clinical trials in cystic fibrosisGerd Döring, J Stuart Elborn, Marie Johannesson, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patientsMichael Mulheran, Pauline Hyman-Taylor, Kelvin H-V Tan, et al.
Pediatrics|December 5, 2006
Asthma as a barrier to children's physical activity: implications for body mass index and mental healthCristine Glazebrook, Amy C McPherson, Ian A Macdonald, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2018
The prevalence, clinical status and genotype of cystic fibrosis patients living in Cuba using national registry dataFidel Rodríguez-Calá, Ramón Suárez-Medina, Silvia Josefina Venero-Fernández, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 11, 2024
Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registriesRebecca Calthorpe, Margaret Rosenfeld, Christopher H Goss, et al.
Lancet (London, England)|February 15, 2005
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trialAlan Smyth, Kelvin H-V Tan, Pauline Hyman-Taylor, et al.
BMJ Open Respiratory Research|September 9, 2020
How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative surveySherie Smith, Nicola Rowbotham, Gwyneth Davies, et al.
BMC Public Health|October 28, 2011
Evaluating the effectiveness of a schools-based programme to promote exercise self-efficacy in children and young people with risk factors for obesity: steps to active kids (STAK)Cris Glazebrook, Martin J Batty, Nivette Mullan, et al.
BMJ Open Respiratory Research|May 3, 2024
Considerations for the use of inhaled antibiotics for <i>Pseudomonas aeruginosa</i> in people with cystic fibrosis receiving CFTR modulator therapyPierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.
Pageof 5